Please assess the completion status of the following clinical trial:

Trial Title: Movicol in Childhood Constipation (ProMotion Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients that, in the opinion of the investigator, are constipated/faecally impacted as to require hospital stay to treat and/or relieve the impaction~* children aged 2 - 11 years old inclusive~* patients of either sex~Exclusion Criteria:~Patients with~* intestinal perforation or obstruction~* severe inflammatory conditions of the intestinal tract~* uncontrolled renal/hepatic/cardiac diseases~* uncontrolled endocrine disorder(s)~* any neuromuscular condition affecting bowel function~* hypersensitivity to lactulose or PEG or other constituent of Movicol~* patients who have taken any investigational drug in the three months~* patients or patients whose parents would in the opinion of the investigator are unable to comply with requirements of the study

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).